Search

Meet our new AseBio member, IGES Pharma. We spoke with Chus Castillo Gutiérrez, General Manager of the Barcelona Branch Office.

BIOSPAIN 2026 will provide the stage for Castilla y León to unveil a new approach to driving innovation in the life sciences.

AseBio believes the reform is moving in the right direction, while calling for regulatory ambition to be maintained throughout the negotiations in order to strengthen European innovation and

The largest funding rounds of 2025 were concentrated in companies that combine an unmet need, solid evidence, and the potential for international scaling.

The funding will support the development of a new generation of high-value natural ingredients, guided by data and targeted at high-impact health applications

Granted claims cover the use of vafidemstat for treating non-aggressive symptoms of BPD.

On World Zoonoses Day, we spoke with HIPRA, one of the European biotechnology companies most strongly committed to the One Health approach.

Priced at €2.70 per share, representing a 14.15% discount on the five day VWAP and a 12.68% discount to the June 30 closing price.

The congress, which will take place in Bilbao from 29 September to 1 October, will dedicate its final day to the Talent Day, an event bringing together companies, researchers, professionals and

Toni Vilaplana, CEO of Viva in Vitro Diagnostics.

The company strengthens its international positioning as a leading provider of sustainable botanical extracts and evidence-based solutions.

A study led by NIEHS/NIH, with participation from Biobide, the US-EPA, the University of Konstanz, and the IUF-Leibniz Institute, published in the journal Neurotoxicology, validates and proposes a

Prolonged overall survival (OS) was observed in heavily pre-treated refractory Head & Neck Squamous Cell Carcinoma (HNSCC) patients administered IV VCN-01 prior to the immune checkpoint inhibitor

A new clinical trial shows that HyperSperm technology, developed by the biotech start-up Fecundis, based at the University of Barcelona Parc Científic de Barcelona (PCB-UB), increases the number of

More than 50 stakeholders gathered in Barcelona in an international Hackathon organized and coordinated by GENESIS Biomed within the PHEMS project.